Regulating Artificial Intelligence

… regulate the use of artificial intelligence in clinical research? How likely is it that AI could lead us to erroneous … data-driven tools. ILCN:  Another potential use for AI in research could be evaluating disease burden. To what extent do … Singh:  FDA recognizes the interest and potential for AI research tools to aid in disease evaluation, such as with …

Narrow Focus Allows Pragmatica-Lung Trial to Minimize Eligibility Criteria, Significantly Reduce Data Collection, Researcher Says

… Criteria, Significantly Reduce Data Collection, Researcher Says … Erin Jungmeyer …

Prof. Caroline Dive Honored with Mary J. Matthews Pathology/Translational Research Award for Work with CTCs

… Honored with Mary J. Matthews Pathology/Translational Research Award for Work with CTCs … Leah Lawrence …

Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors

… Translating Early Research to Adapt CAR T-Cell Therapy to Solid Tumors …

Funding Opportunities for Innovative Multidisciplinary Cancer Research Teams

… Opportunities for Innovative Multidisciplinary Cancer Research Teams …

Program Trains Patient Research Advocates to be STARS

… Program Trains Patient Research Advocates to be STARS … Lauren Evoy Davis …

US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective

… of care and limited resources to review applications, researchers say they support the agency’s decision not to …

Proposed Criteria for Tumor Invasion Align with Clinical Factors, Offer Better Predictability, Study Finds

… Researchers evaluating the clinical significance of …

Pragmatic Approach to Trial Design Born from Lung-MAP Substudy

… new pragmatic approach to trial design can streamline research and ultimately benefit patients. … Pragmatic Approach …

Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates

… Researchers say increased screening of at-risk populations, …

US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR

… In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited …

Recurrence Remains a Risk Even for Patients Diagnosed via Screening

… immunotherapy and improved novel and targeted therapies. Research evaluating the survival benefit of early recurrence …